Recursion Pharmaceuticals Growth, Revenue, Number of Employees and Funding

Overview

Location:
Total Funding:$141.3M
Industry:Pharma
Founded:2013
Lead Investor(s):Square 1 Bank
Press

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Recursion Pharmaceuticals's estimated revenue is currently $18.9M per year.
  • Recursion Pharmaceuticals received $20.5M in venture funding in June 2018.
  • Recursion Pharmaceuticals's estimated revenue per employee is $134857
  • Recursion Pharmaceuticals's total funding is $141.3M.

Employee Data

  • Recursion Pharmaceuticals has 140 Employees.
  • Recursion Pharmaceuticals grew their employee count by 36% last year.
  • Recursion Pharmaceuticals currently has 4 job openings.

What Is Recursion Pharmaceuticals?

Recursion Pharmaceuticals has developed a powerful drug discovery platform involving millions of rapid, automated experiments and analysis to discover new therapeutics. Our platform has resulted in the massive parallelization of drug discovery. We have deployed this platform in pursuit of drugs for the treatment of rare genetic diseases. We partner or out-license these leads to major pharmaceutical companies early in development. Our horizontal business model focused on discovery accelerates our impact and reduces our costs by avoiding slow and costly in-house development, and allows us to spread risk across many new therapeutic opportunities.

keywords:Biotechnology,Healthcare,Pharmaceuticals

140

Number of Employees

$18.9M

Revenue (est)

4

Current Jobs

36%

Employee Growth %

$141.3M

Total Funding

N/A

Valuation

N/A

Accelerator

B2C

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Recursion Pharm...
$18.9M14036%$141.3M

Recursion Pharmaceuticals News

09/07/2019 - Metachromatic Leukodystrophy (MLD) Treatment Market 2019 ...

... Leukodystrophy (MLD) Treatment Market 2019 : Global Analysis Report (ArmaGen Inc, GlaxoSmithKline Plc, Recursion Pharmaceuticals Inc).

09/08/2019 - Artificial Intelligence – Transforming the future of Healthcare Market 2019-2026 | Top Key Player are Imagia Cybernetics,Nuritas,Elsevier,Recursion Pharmaceuticals,BenevolentAI,SOPHiA

The key players covered @ Imagia Cybernetics,Nuritas,Elsevier,Recursion Pharmaceuticals,BenevolentAI,SOPHiA GENETICS,Virvio,NuMedii ...

07/15/2019 - AI drug prospector Recursion Pharma nets $121M for its ...

Recursion Pharmaceuticals also said it plans to prioritize treatments for rare diseases within its pipeline while seeking drugmaker partnerships ...

Recursion Pharmaceuticals Funding

DateAmountRoundLead InvestorsReference
2015-12-08$2.6MUndisclosedArticle
2016-10-04$12.9MALux CapitalArticle
2016-11-23$2.2MAFelicis VenturesArticle
2017-02-10$4.0MUndisclosedSquare 1 BankArticle
2017-10-04$60.0MBData Collective (DCVC)Article
2018-06-06$20.5MUndisclosedSquare 1 BankArticle

Recursion Pharmaceuticals Executive Hires

DateNameTitleReference
2016-10-26John PereiraCOOArticle
2018-05-02Kevin LynchChief Business OfficerArticle
2018-05-16Phil CarpinoDir ChemistryArticle
2018-07-11Tina LarsonChief Operating OfficerArticle